Trending...
- IDEMIA Awarded 10-Year Blanket Purchase Agreement from the General Services Administration for Next-Generation Identity Proofing for Login.Gov - 309
- Sarah Novotny Joins Kosai as a Board Advisor: A New Chapter for Open Source Leadership
- NY Implant Dentistry - Dr. Greg R. Diamond, DDS – Your Trusted Dentist in NYC, New York
NEW YORK, Jan. 8, 2025 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against BioAge Labs, Inc. ("BioAge" or the "Company") (NASDAQ: BIOA). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged to include their mailing address, telephone number, and the number of shares purchased.
The class action concerns whether BioAge and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices.
You have until March 10, 2025, to ask the Court to appoint you as Lead Plaintiff for the class if you are a shareholder who purchased or otherwise acquired BioAge securities during the Class Period. A copy of the Complaint can be obtained at www.pomerantzlaw.com.
More on Nyenta.com
[Click here for information about joining the class action]
On or around September 26, 2024, BioAge conducted its initial public offering ("IPO"), selling 12.65 million shares of common stock priced at $18.00 per share. Then, on December 6, 2024, BioAge announced that it would discontinue the ongoing STRIDES Phase 2 study of its investigational drug candidate azelaprag after liver transaminitis was observed in some subjects receiving azelapgrag.
On this news, BioAge's stock price fell $15.44 per share, or 76.85%, to close at $4.65 per share on December 9, 2024.
Pomerantz LLP, with offices in New York, Chicago, Los Angeles, London, Paris, and Tel Aviv, is acknowledged as one of the premier firms in the areas of corporate, securities, and antitrust class litigation. Founded by the late Abraham L. Pomerantz, known as the dean of the class action bar, Pomerantz pioneered the field of securities class actions. Today, more than 85 years later, Pomerantz continues in the tradition he established, fighting for the rights of the victims of securities fraud, breaches of fiduciary duty, and corporate misconduct. The Firm has recovered numerous multimillion-dollar damages awards on behalf of class members. See www.pomlaw.com.
More on Nyenta.com
Attorney advertising. Prior results do not guarantee similar outcomes.
CONTACT:
Danielle Peyton
Pomerantz LLP
[email protected]
646-581-9980 ext. 7980
SOURCE Pomerantz LLP
The class action concerns whether BioAge and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices.
You have until March 10, 2025, to ask the Court to appoint you as Lead Plaintiff for the class if you are a shareholder who purchased or otherwise acquired BioAge securities during the Class Period. A copy of the Complaint can be obtained at www.pomerantzlaw.com.
More on Nyenta.com
- Exciting News: Gourmet Meal Kiosks Coming to Wilmorite Malls in Rochester, NY!
- Holistic Energy Bodyworks Launches New Website to Transform Wellness
- Yonkers: HOLLYWOOD ON HUDSON: YONKERS FILM AND TELEVISION PRODUCTION SOARS IN 2024
- Genuine Hospitality, LLC Expands Leadership Team with Key Appointments
- TilePix x Jonathan Adler Introduce The Jet Set Collection
[Click here for information about joining the class action]
On or around September 26, 2024, BioAge conducted its initial public offering ("IPO"), selling 12.65 million shares of common stock priced at $18.00 per share. Then, on December 6, 2024, BioAge announced that it would discontinue the ongoing STRIDES Phase 2 study of its investigational drug candidate azelaprag after liver transaminitis was observed in some subjects receiving azelapgrag.
On this news, BioAge's stock price fell $15.44 per share, or 76.85%, to close at $4.65 per share on December 9, 2024.
Pomerantz LLP, with offices in New York, Chicago, Los Angeles, London, Paris, and Tel Aviv, is acknowledged as one of the premier firms in the areas of corporate, securities, and antitrust class litigation. Founded by the late Abraham L. Pomerantz, known as the dean of the class action bar, Pomerantz pioneered the field of securities class actions. Today, more than 85 years later, Pomerantz continues in the tradition he established, fighting for the rights of the victims of securities fraud, breaches of fiduciary duty, and corporate misconduct. The Firm has recovered numerous multimillion-dollar damages awards on behalf of class members. See www.pomlaw.com.
More on Nyenta.com
- New-and-Improved Caribbean-Food Website Dishes Out Free Ground-Shipping Offer; Affiliate Program Garnished with Generous Commission
- 50th Mount Dora Arts Festival set for Feb 1 and 2, 2024
- CCHR Cites Newly Released Mind Control Records to Oppose Psychedelics
- K2 Integrity Appoints Markus Schulz as Chief Technology Officer
- LINE FRIENDS and HoYoverse to Debut Genshin minini POP-UP at LINE FRIENDS Flagship Store in New York City's Times Square Starting January 22nd
Attorney advertising. Prior results do not guarantee similar outcomes.
CONTACT:
Danielle Peyton
Pomerantz LLP
[email protected]
646-581-9980 ext. 7980
SOURCE Pomerantz LLP
Filed Under: Business
0 Comments
Latest on Nyenta.com
- LIB: A master of ingenuity in the field of custom test chambers, unlocking unlimited possibilities!
- Anatomage Announces Acquisition of Cloud-based Software Company BioDigital
- PRP Aviation Earns Prestigious "Platinum Cirrus Training Center" Designation
- SHAREHOLDER ALERT: The M&A Class Action Firm Continues To Investigate The Merger - SDIG, IPXX, KAVL, ML
- New Rochelle Job Fair at City Hall, Wednesday, January 22
- Richard Contino's 'Equipment Leasing and Financing' A Manufacturer's Guide to Captive Financing
- MongoDB, Inc. to Present at the 27th Annual Needham Growth Conference
- Growth Marshal Publishes Comprehensive Guide to Content Marketing for CEOs
- Cyrus Webb and Conversations Media Group Providing New Opportunities for Authors and Creatives to Shine and Thrive
- Tam Tam Named Best Children's Music Education & Wellness Organization in New York
- Westchester Network for Professionals Launches Exclusive New Year Membership Offer
- Seeking Sponsors for the BizNetwork Destination Tours Launch Party & Networking Social Gala
- Inframark Acquires Cornerstone Properties, Inc., Expanding Community Management Services in Arizona
- Loose, Uncomfortable Dentures? Get a Same-Day Reline While-U-Wait!
- IDEMIA Awarded 10-Year Blanket Purchase Agreement from the General Services Administration for Next-Generation Identity Proofing for Login.Gov
- New Report Highlights Opportunities and Barriers in Finger Lakes Clean Energy Workforce
- Rochester: Statement by Mayor Evans regarding life of President Jimmy Carter on National Day of Mourning
- NY Implant Dentistry - Dr. Greg R. Diamond, DDS – Your Trusted Dentist in NYC, New York
- ITURAN ANNOUNCES PARTICIPATION IN UPCOMING CONFERENCES IN JANUARY 2025